Takahide Noro

Chiba Cancer Center

Papers

1

Total Citations

4

H-Index

1

About

Dr. Takahide Noro is a leading urologic oncologist whose research focuses on refining surgical strategies for prostate cancer, particularly in the era of robotic surgery. His major contribution lies in the development and validation of a novel nomogram designed to identify optimal candidates for extended pelvic lymph node dissection (ePLND) among Japanese patients undergoing robot-assisted radical prostatectomy. This work addresses a critical clinical challenge: balancing the diagnostic benefits of ePLND against its potential morbidity. By analyzing a cohort of 538 patients, Dr. Noro’s nomogram provides a personalized, risk-stratified approach to predict lymph node invasion, helping surgeons avoid unnecessary dissections in low-risk patients while ensuring high-risk individuals receive appropriate staging. Though a recent publication (2023), his study has already garnered 4 citations, signaling its immediate relevance and adoption within the urologic community. Dr. Noro’s research exemplifies the shift toward precision medicine in surgical oncology, offering a practical tool that enhances decision-making in the robotic era. His work is particularly impactful for clinicians seeking to optimize outcomes in prostate cancer management.

Research Focus

Key Achievements

1
H-Index
1
Papers
4
Total Citations
4
Avg Citations/Paper
🏆 Most Cited Paper
Development and validation of novel nomogram to identify the candidates for extended pelvic lymph node dissection for prostate cancer patients in the robotic era
4 citations · 2023
📈 Most Prolific Year: 2023 (1 Papers)
🤝 Key Collaborators: 17
🏛 Institutions: Chiba Cancer Center

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago